Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-03-04 @ 9:36 PM
Study NCT ID:
NCT02668393
Status:
COMPLETED
Last Update Posted:
2021-01-29
First Post:
2016-01-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-27
First Submit QC Date:
None
Study First Post Date:
2016-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-11-24
Results First Submit QC Date:
None
Results First Post Date:
2021-01-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-11
Last Update Post Date:
2021-01-29
Last Update Post Date Type:
ACTUAL